Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839760 · ClinicalTrials.gov registry record
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients
A clinical trial, sponsored by Crucell Holland.
- Completed
- Registry status
- 150
- Enrollment target
NCT01839760: Completed study, sponsored by Crucell Holland.
NCT01839760 is a clinical trial that has completed, run by Crucell Holland. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01839760 has completed, sponsored by Crucell Holland.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifestations and prognosis.
Primary Outcome
Outcome is the decay rate in viral load during hospital stay measured by quantitative polymerase chain reaction (QPCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-01 |
What the finished NCT01839760 record still lists
NCT01839760 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01839760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01839760 about?
NCT01839760 is a clinical study titled "Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients". The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifest...
What is the current status of trial NCT01839760?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2012-12. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01839760?
This trial is sponsored by Crucell Holland, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia